Fundraising FoxOxford Angel Fund — Full Portfolio
10 tracked investments · listed companies and verified rows first
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)in
BoardSurbhi Sarna(Director)in
Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+35 more
Apero is a healthcare software platform that provides scheduling, visit notes, revenue cycle management, patient billing, prescriptions, and financial reporting for medical practices.
HealthtechSaaSSan Francisco, US
Jacinda Shelly(Founder)inNick Shelly(Founder)in
Co-investorsInitialized CapitalJude GomilaOxonian VenturesSoma CapitalUpHonest CapitalVentureSouq+10 more
BluumBio identifies and deploys naturally occurring enzymes from fungi, trees, and bacteria to remove industrial pollutants from soil, air, and water.
BiotechCleantechHealthtechImpact & Social GoodSan Francisco, US
Katherine French(Founder)in
Co-investorsCollaborative FundHAWKTAILOlive Tree CapitalOxonian VenturesY CombinatorAgrolimen Ventures+8 more
Conductor develops AI algorithms and control software for quantum computing, helping researchers and engineers optimize qubit architectures and scaling in semiconductor-based quantum systems.
Advanced ManufacturingAI & Machine LearningDeep TechQuantum ComputingSan Francisco, US
Brandon Severin(Co-Founder & CEO)inJoel Pendleton(Co-Founder & CTO)in
Co-investorsDG Daiwa VenturesMoonfire VenturesMyAsiaVCOlive Tree CapitalOUTBOUND CAPITALOxonian Ventures+16 more
ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Thomas Folliard(Founder)in
Co-investorsGravityJude GomilaOxonian VenturesPi CampusY CombinatorZAKA VC+9 more
Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
BiotechDeep TechDigital HealthHealthtechSan Francisco, US
Prof. Dustin(Co-founder)Ashwin Nandakumar(Founder)inAshwin Jainarayanan(Founder)inAshwin Menon Nandakumar(Founder)in
Co-investorsFelicis VenturesMetaplanetOxonian VenturesPioneerRitual CapitalY Combinator+4 more
Ligo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.
AI & Machine LearningBiotechClimate TechDeep TechHealthtechSan Francisco, US
Edward Harris(Founder)inEmily Egerton-Warburton(Founder)inArda Goreci(Founder)in
Co-investorsA.Capital VenturesHAWKTAILOxonian VenturesSoma CapitalTranspose Platform ManagementWayfinder Ventures+15 more
Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Lukas Lange(Founder)in
Co-investorsAsymmetric Capital PartnersCalm/Storm VCManta Ray VenturesOxonian VenturesRecode VenturesThink+ Ventures Management, Llc+6 more
Proof provides online notarization and identity verification tools to establish trust for agreements and records executed remotely.
CybersecurityEnterprise SoftwareFintechGovTechLegalTechMarketplacesSaaS
Pat Kinsel(Founder & CEO)inLeandra Fishman(Chief Revenue Officer)Eric Fleischman(Chief Technology Officer)Renee Hunter(Chief Legal Officer)Darren Louie(Head of Product)Ian Macallister
Co-investorsCamber CreekCanapi VenturesCapitalGCurql Collective, LLCEthos VCJovono+7 more
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Co-Founder & CEO)inIrsyad Khairil(Co-Founder & CTO)in
Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesP53 InvestSynBioVen+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.